Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis
CONCLUSIONS: The results highlight opportunities to improve initiation of XR-NTX in high-need groups. Addressing expectations regarding induction may enhance XR-NTX initiation rates. Trial Registration ClinicalTrials.gov: NCT03275350. Registered September 7, 2017. https://clinicaltrials.gov/ct2/show/NCT03275350?term=extended+release+naltrexone&cond=Opioid+Use .PMID:34758887 | DOI:10.1186/s13722-021-00277-z
Source: Addiction Science and Clinical Practice - Category: Addiction Authors: Kim A Hoffman Robin Baker Laura C Fanucchi Paula J Lum Lynn E Kunkel Javier Ponce Terashima Dennis McCarty Petra Jacobs P Todd Korthuis Source Type: research
More News: Addiction | African Health | Anxiety | Environmental Health | Methadone | Science | Study | Women